PROCTER & GAMBLE HEALTH | NATCO PHARMA | PROCTER & GAMBLE HEALTH/ NATCO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 35.0 | 14.1 | 247.5% | View Chart |
P/BV | x | 10.7 | 3.7 | 287.9% | View Chart |
Dividend Yield | % | 2.0 | 0.5 | 364.7% |
PROCTER & GAMBLE HEALTH NATCO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
NATCO PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ NATCO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 847 | 633.7% | |
Low | Rs | 3,883 | 502 | 773.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 148.4 | 499.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 39.2 | 352.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 48.2 | 322.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 5.50 | 1,727.3% | |
Avg Dividend yield | % | 2.1 | 0.8 | 251.9% | |
Book value per share (Unadj.) | Rs | 447.6 | 267.1 | 167.6% | |
Shares outstanding (eoy) | m | 16.60 | 182.47 | 9.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 4.5 | 137.3% | |
Avg P/E ratio | x | 33.5 | 17.2 | 194.5% | |
P/CF ratio (eoy) | x | 29.8 | 14.0 | 212.9% | |
Price / Book Value ratio | x | 10.3 | 2.5 | 409.2% | |
Dividend payout | % | 68.7 | 14.0 | 489.8% | |
Avg Mkt Cap | Rs m | 76,761 | 123,049 | 62.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 4,867 | 42.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 27,071 | 45.4% | |
Other income | Rs m | 184 | 1,285 | 14.3% | |
Total revenues | Rs m | 12,480 | 28,356 | 44.0% | |
Gross profit | Rs m | 3,247 | 9,117 | 35.6% | |
Depreciation | Rs m | 281 | 1,638 | 17.2% | |
Interest | Rs m | 8 | 145 | 5.3% | |
Profit before tax | Rs m | 3,142 | 8,619 | 36.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 1,466 | 57.8% | |
Profit after tax | Rs m | 2,295 | 7,153 | 32.1% | |
Gross profit margin | % | 26.4 | 33.7 | 78.4% | |
Effective tax rate | % | 27.0 | 17.0 | 158.5% | |
Net profit margin | % | 18.7 | 26.4 | 70.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 30,003 | 39.0% | |
Current liabilities | Rs m | 6,791 | 6,831 | 99.4% | |
Net working cap to sales | % | 40.0 | 85.6 | 46.8% | |
Current ratio | x | 1.7 | 4.4 | 39.3% | |
Inventory Days | Days | 263 | 63 | 413.9% | |
Debtors Days | Days | 343 | 115 | 297.6% | |
Net fixed assets | Rs m | 10,617 | 26,571 | 40.0% | |
Share capital | Rs m | 166 | 365 | 45.5% | |
"Free" reserves | Rs m | 7,265 | 48,373 | 15.0% | |
Net worth | Rs m | 7,431 | 48,738 | 15.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 56,574 | 39.5% | |
Interest coverage | x | 409.1 | 60.4 | 676.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.5 | 115.1% | |
Return on assets | % | 10.3 | 12.9 | 79.9% | |
Return on equity | % | 30.9 | 14.7 | 210.4% | |
Return on capital | % | 42.4 | 18.0 | 235.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 10.2 | 127.5% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | 2,772 | 57.9% | |
Fx inflow | Rs m | 1,465 | 17,256 | 8.5% | |
Fx outflow | Rs m | 1,605 | 2,772 | 57.9% | |
Net fx | Rs m | -140 | 14,484 | -1.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 8,491 | 27.8% | |
From Investments | Rs m | -215 | -4,771 | 4.5% | |
From Financial Activity | Rs m | -985 | -3,630 | 27.1% | |
Net Cashflow | Rs m | 1,160 | 208 | 557.8% |
Indian Promoters | % | 0.0 | 49.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 25.8 | 77.3% | |
FIIs | % | 6.2 | 16.1 | 38.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 50.3 | 95.8% | |
Shareholders | 56,778 | 228,467 | 24.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Natco Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.06% | -2.26% | 0.34% |
1-Month | -0.15% | 3.43% | 0.25% |
1-Year | 2.57% | 72.51% | 54.31% |
3-Year CAGR | -9.17% | 4.21% | 15.04% |
5-Year CAGR | 5.13% | 13.12% | 19.87% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Natco Pharma share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Natco Pharma the stake stands at 49.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Natco Pharma.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Natco Pharma.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.